Personalis and Tempus AI Extend Commercial Deal to Biopharma Industry

TipRanks08:15 ET

Express News | Personalis and Tempus Expand Collaboration to Biopharma

Reuters08:00 ET

Insiders Own 36% of Tempus AI, Inc (NASDAQ:TEM) in Spite of Selling Recently and the Recent Dip May Have Hurt Them

Yahoo FinanceDec 14 09:11 ET

With A 40% Price Drop For Tempus AI, Inc (NASDAQ:TEM) You'll Still Get What You Pay For

Simply Wall StDec 14 07:35 ET

Insider Sale: EVP and General Counsel of $TEM (TEM) Sells 3,900 Shares

Quiver QuantitativeDec 13 18:31 ET

Tempus AI(TEM.US) Officer Sells US$3.94 Million in Common Stock

Moomoo NewsDec 13 18:22 ET